Skip to main content
logo
Genmab A/S (GNMSF)
OTCMKTS · Delayed Price · Currency is USD
330.63
0.00 (0.00%)
At close: Feb 3, 2026

Genmab Revenue

Genmab had revenue of $1.02B in the quarter ending September 30, 2025, with 23.34% growth. This brings the company's revenue in the last twelve months to $3.85B, up 29.57% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.

Revenue (ttm)
3.85B
Revenue Growth
+29.57%
P/S Ratio
4.96
Revenue / Employee
1.43M
Employees
2,681
Market Cap
19.08B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.99B545.24M22.32%
Dec 31, 20232.44B358.99M17.23%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 20201.66B855.79M106.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioStem Technologies292.21M
Vaxart148.20M
Silence Therapeutics25.83M
Nuo Therapeutics2.61M
Northwest Biotherapeutics937.00K
Arch Biopartners198.11K
Revenue Rankings

Genmab News

More News